Erik Gustaf Klintmalm

Positions Held:
American College of Dentists Board Intern

Education:
D.M.D., Arizona School of Dentistry and Oral Health, 2018
M.P.H., Arizona School of Dentistry and Oral Health, 2018
Certificate in Biomedical Sciences, Drexel College of Medicine, 2012
M.A., Bioethics, New York University, 2011
B.A., Biochemistry, Baylor University, 2010
B.A., Biology, Baylor University, 2010
B.A., Philosophy, Baylor University, 2010

Areas of Research/Interest:
Dental ethics, clinical ethics, ethic decision making, patient-healthcare provider relationships

Bio:
Erik grew up in both the United States and in Sweden, where he was born. He attended the Claremont Colleges for a brief time before transferring to Baylor University. There he studied both science and philosophy. After graduating he moved to New York to obtain his master’s of Bioethics, the perfect marriage between science and philosophy. Currently he lives in Dallas, TX where he studies and volunteers. His interest lies in clinical ethics, ethical decision making and the patient-healthcare provider relationship. Ultimately, his goal is to become a practicing dentist and work in dental policy and community outreach. His hobbies include cooking, racquetball, piano and computers.

Fellowships, Honors, and Memberships:
Member, American Society of Dental Ethics
The Bioethics Fellowship Fund, given by the NYU Bioethics Program, August 2010
The Moses Fellowship, given by the NYU Center for Bioethics, August 2010
European Society of Transplant, “Top Selection” — “The Impact of Sirolimus on Weight Change in Liver Transplantation: A Clinical Picture of a Complex Interaction” Paris, France Sept 2009 American Association For the Study of Liver Disease “Presidential Poster of Distinction” — The Impact of Sirolimus on Hepatitis C Progression in Liver Transplant Recipients”, Boston, MA Oct 2009

Publications:
GJ McKenna, JF Trotter, E Klintmalm, et al. Limiting hepatitis C virus progression in liver transplant recipients using sirolimus based immunosuppression. Am J Transplant 2011; 11(11): 2379-87.
GJ McKenna, JF Trotter, E Klintmalm, et al. “De Novo Sirolimus Immunosuppression in Liver Transplantation: Reassessing the Black Box Warning For Hepatic Artery Complications. Liver Transplantation 2012 (Submitted for review)
GJ McKenna, JF Trotter, E Klintmalm, et al. “Sirolimus and Cardiovascular Risk in Liver Transplantation: Much Ado About Nothing ? Transplantation 2012 (Submitted for review)
GJ McKenna, JF Trotter, E Klintmalm, et al. “The Impact of Timing in Sirolimus Conversion for Renal Insufficiency in Liver Transplant Recipients” 2012 (In Preparation)
GJ McKenna, JF Trotter, E Klintmalm, et al. “The Effect of Sirolimus on Body Weight in Liver Transplant Recipients” 2012 (In Preparation)
GJ McKenna, J Trotter, E Klintmalm, et al. “Limiting Hepatitis C Virus (HCV) Progression in Liver Transplant Recipients Using De Novo Sirolimus Based Immunosuppression.”
GJ McKenna , J Trotter, E Klintmalm, et al. “The Impact of Sirolimus on Body Weight in Liver Transplantation: Can We Limit A Major Comorbidty?”
GJ McKenna , J Trotter, E Klintmalm, et al. “Sirolimus and Hepatic Artery Complications: Reassessing the Black Box Warning ?”

Contact:
erik.klintmalm@gmail.com